Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 6/2013

01-12-2013 | Erratum

Erratum to: Effect of HSP90 inhibitor in pheochromocytoma PC12 cells: an experimental investigation

Authors: Yunze Xu, Chongyu Zhang, Dongning Chen, Juping Zhao, Zhoujun Shen, Yuxuan Wu, Yu Zhu

Published in: Tumor Biology | Issue 6/2013

Login to get access

Excerpt

Erratum to: Tumor Biol. …
Metadata
Title
Erratum to: Effect of HSP90 inhibitor in pheochromocytoma PC12 cells: an experimental investigation
Authors
Yunze Xu
Chongyu Zhang
Dongning Chen
Juping Zhao
Zhoujun Shen
Yuxuan Wu
Yu Zhu
Publication date
01-12-2013
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 6/2013
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1091-6

Other articles of this Issue 6/2013

Tumor Biology 6/2013 Go to the issue

Research Article

Cyclooxygenase-2 polymorphisms were associated with the risk of gastric cancer: evidence from a meta-analysis based on case–control studies

Research Article

High plasma D-dimer level is associated with decreased survival in patients with lung cancer: a meta-analysis

Research Article

Effect of HSP90 inhibitor in pheochromocytoma PC12 cells: an experimental investigation

Research Article

Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer

Research Article

TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression

Research Article

Association between FAS A670G polymorphism and susceptibility to cervical cancer: evidence from a meta-analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits